Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Equity (2018 - 2025)

Historic Return on Equity for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to 2.37%.

  • Cue Biopharma's Return on Equity fell 5200.0% to 2.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.37%, marking a year-over-year decrease of 5200.0%. This contributed to the annual value of 1.46% for FY2024, which is 5000.0% down from last year.
  • As of Q3 2025, Cue Biopharma's Return on Equity stood at 2.37%, which was down 5200.0% from 3.1% recorded in Q2 2025.
  • Over the past 5 years, Cue Biopharma's Return on Equity peaked at 0.6% during Q1 2021, and registered a low of 3.31% during Q1 2025.
  • Its 5-year average for Return on Equity is 1.35%, with a median of 1.01% in 2023.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 1700bps in 2021, then crashed by -18600bps in 2025.
  • Quarter analysis of 5 years shows Cue Biopharma's Return on Equity stood at 0.68% in 2021, then crashed by -34bps to 0.9% in 2022, then tumbled by -37bps to 1.24% in 2023, then plummeted by -50bps to 1.86% in 2024, then decreased by -28bps to 2.37% in 2025.
  • Its last three reported values are 2.37% in Q3 2025, 3.1% for Q2 2025, and 3.31% during Q1 2025.